CollaGenex Pharmaceuticals, West-ward Settle Patent Suit

Law360, New York (November 10, 2003, 12:00 AM EST) -- Dental and dermatological drugmaker CollaGenex and generic drugmaker West-ward Pharmaceutical Corporation settled all their pending litigation concerning patents for a periodontitis treatment, the two companies said Monday.

CollaGenex had sued West-ward and other defendants in the United States District Court for the Eastern District of New York, alleging that West-ward infringed CollaGenex's patents for Periostat for the treatment of adult periodontitis.

CollaGenex's complaint also alleged that West-ward infringed CollaGenex's patent rights under the Hatch-Waxman act by submitting an Abbreviated New Drug Application with the Food and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.